Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
At the heart of COVID-19
Inayat Hussain Khan1, Syeda Anum Zahra1, Sevim Zaim2
1Department of Medicine, St George's Hospital Medical School, London, UK.
Insights
Coronavirus disease (COVID-19) impacts the cardiovascular system, especially in older adults and those with comorbidities. Research is ongoing into COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease (COVID-19) emerged in late 2019 and rapidly became a global pandemic.
- While COVID-19 affects all demographics, older individuals and those with comorbidities face higher risks of severe disease and adverse outcomes.
- Pre-existing cardiovascular disease (CVD) may increase vulnerability to COVID-19, though its prevalence in affected patients is under-reported.
Purpose of the Study:
- To review recent advancements in understanding the complex interplay between COVID-19 and the cardiovascular system.
- To explore the potential direct and indirect mechanisms through which COVID-19 affects cardiovascular health.
- To highlight the role of angiotensin-converting enzyme 2 (ACE2) in both cardiovascular disease and COVID-19 pathogenesis.
Main Methods:
- This is a review article, synthesizing current scientific literature.
- The review focuses on recent research concerning COVID-19's cardiovascular implications.
- Key areas examined include pathogenic mechanisms and potential therapeutic targets.
Main Results:
- COVID-19 can directly and indirectly impact the cardiovascular system, although precise mechanisms require further elucidation.
- Angiotensin-converting enzyme 2 (ACE2) is implicated in the pathogenesis of COVID-19 and has known cardiovascular effects.
- Research is actively exploring antiviral treatments and vaccines for COVID-19.
Conclusions:
- Understanding the cardiovascular effects of COVID-19 is crucial for managing patients during the pandemic.
- Further research is needed to clarify the specific pathways of cardiovascular involvement and to develop targeted therapies.
- The ongoing development of antivirals and vaccines remains a priority in combating COVID-19.
Abstract:
Coronavirus disease (COVID-19) first presented in Wuhan, Hubei province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. The disease does not discriminate but increasing age and the presence of comorbidities are associated with severe form of the disease and poor outcomes. Although the prevalence of COVID-19 in patients with cardiovascular disease is under-reported, there is evidence that pre-existing cardiac disease can render individuals vulnerable. It is thought that COVID-19 may have both a direct and indirect effect on the cardiovascular system; however, the primary mechanism of underlying cardiovascular involvement is still uncertain. Of particular interest is the role of angiotensin-converting enzyme 2, which is well known for its cardiovascular effects and is also considered to be important in the pathogenesis of COVID-19. With a range of different drug candidates being suggested, effective anti-virals and vaccines are an area of on-going research. While our knowledge of COVID-19 continues to rapidly expand, this review highlights recent advances in our understanding of the interaction between COVID-19 and the cardiovascular system.
More Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Mechanisms of Retrovirus-induced Cancers
Types of Impact
The coefficient of restitution is a metric for understanding the dynamics of impacts. It quantifies the ratio of relative velocity...
Causality in Epidemiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

